Cell Transfer Therapy of Cancer Metastasis with Autologous Lymphocytes

Sekine T. ; Shiraiwa H. ; Yamazaki T. ; Tobisu K. ; Kakizoe T. A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. Biomed. Pharmacother. 47: 73–78; 1993.

Miesowicz F. ; du Moulin G. ; Liu V. ; Hamilton D. ; Davies B. ; Pitkin Z. ; Stack J. ; Chew-Darke J. ; Osband M. Development and implementation of delivery and quality control system for cellular therapies: Experience in 500 patients. Cell Transplant. 3(Suppl. 1): S53; 1994.

Sekiguchi M. ; Mikamo S. Adoptive immunotherapy of cancer patients with anti-CD3 activated autologous lymphocytes. In: Recent advances in life sciences. Edited and published by The 14th International Symposium Organizing Committee, Korea; 1993: 17–32.

Mikamo S. Adoptive immunotherapy using immobilized anti-CD3 mAb-activated autologous lymphocytes: the strong cytotoxicity was supported by CD16+ cells which proliferated in prolonged cultures. [English abstract]. Human Cell 5: 256–266; 1992.

Gismondi A. ; Mainiero F. ; Morrone S. ; Palmieri G. ; Piccoli M. ; Frati L. ; Santoni A. Triggering through CD 16 or phorbol esters enhances adhesion of NK cells to laminin via very late antigen 6. J. Exp. Med. 176: 1251–1257; 1992.

Anegon I. ; Cuturi M.C. ; Trinchieri G. ; Perussia B. Interaction of Fc receptor (CD 16) ligands induces transcription of interleukin 2 receptor (CD 25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167: 452–472; 1988.